A study by renowned American economist Edwin Mansfield suggests that 60% of new drugs would not be invented without patent protection, highlighting the importance of patent protection in the pharmaceutical industry today.
Daiichi Sankyo has entered into a clinical trial collaboration agreement with a subsidiary of Merck to evaluate the combination of Daiichi Sankyo's investigational HER2 targeting antibody drug conjugate DS-8201 and Keytruda (pembrolizumab) in HER2 express